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Neuronal AMPA receptors autoinactivate at high
concentrations of glutamate, i.e., the current declines
at glutamate concentrations above 10–100 mM.
The mechanisms underlying this phenomenon are
unclear. Stargazin-like TARPs are AMPA receptor
auxiliary subunits that modulate receptor trafficking
and channel properties. Here, we found that neuronal
AMPA receptors and recombinant AMPA receptors
coexpressed with stargazin autoinactivate at high
concentrations of glutamate, whereas recombinant
AMPA receptors expressed alone do not. The reduc-
tion of currents at high glutamate concentrations is
not associated with a reduction of AMPA receptor
number, but rather with the loss of stargazin-associ-
ated allosteric modulation of channel gating. We
show that receptor desensitization promotes the
dissociation of TARP-AMPA receptor complexes in
a few milliseconds. This dissociation mechanism
contributes to synaptic short-term modulation. The
results demonstrate a mechanism for dynamic regu-
lation of AMPA receptor activity to tune synaptic
strength.
INTRODUCTION
Glutamate is the most abundant excitatory neurotransmitter in
the brain and acts on three classes of ionotropic glutamate
receptors (AMPA, NMDA, and kainate), which function distinctly
(Dingledine et al., 1999; Hollmann and Heinemann, 1994; See-
burg, 1993). AMPA receptors mediate fast synaptic transmis-
sion, whereas NMDA receptors and kainate receptors are
involved in synaptic plasticity (Kandel, 2001; Lerma, 2006; Mal-
enka and Nicoll, 1999; Nicoll and Schmitz, 2005). Together,
these three classes of glutamate receptors control andmodulate
neural circuits in the brain that underlie aspects of cognitive
function.
AMPA receptors are hetero-oligomers composed of four
subunits, GluR1-4 (Hollmann and Heinemann, 1994; Seeburg,
1993), each of which is alternatively spliced to yield two isoforms(flip and flop) (Sommer et al., 1990). Channels composed of
different AMPA receptor subunits display quantitative differ-
ences in the kinetics of deactivation (channel closure upon gluta-
mate removal) and desensitization (channel closure during
continuous exposure to glutamate) (Jonas and Spruston,
1994), and the subunit composition of AMPA receptors plays
amajor role in controlling the decay of EPSCs. Although the rules
that determine the trafficking of heteromeric AMPA receptors
remain uncertain, the subunit composition of AMPA receptors
also influences the number of synaptic AMPA receptors under
basal and activity-dependent conditions (Barry and Ziff, 2002;
Malinow and Malenka, 2002; Sheng and Kim, 2002; Song and
Huganir, 2002).
The transmembrane AMPA receptor regulatory proteins
(TARPs) are auxiliary subunits of AMPA receptors (Nicoll et al.,
2006; Ziff, 2007). TARPs consist of four typical isoforms (starga-
zin/g-2, g-3, g-4, g-8) and one atypical isoform (g-7), which each
show distinct expression patterns in the brain (Fukaya et al.,
2005; Kato et al., 2007; Tomita et al., 2003) and are evolutionally
conserved (Walker et al., 2006). TARPs bind to AMPA receptors
(Fukata et al., 2005; Nakagawa et al., 2005; Tomita et al., 2003;
Vandenberghe et al., 2005) and modulate both their trafficking
and channel properties (Chen et al., 2000; Kott et al., 2007; Priel
et al., 2005; Tomita et al., 2005a, 2004; Turetsky et al., 2005;
Yamazaki et al., 2004). Mice in which the stargazin/g-2 gene is
disrupted (stargazer) show loss of AMPA receptor activity in
cerebellar granule cells (Chen et al., 2000; Hashimoto et al.,
1999). In addition, TARP g-8 knockout mice have altered
AMPA receptor trafficking and AMPA receptor activity in the
hippocampus (Fukaya et al., 2006; Rouach et al., 2005). TARPs
also control EPSC kinetics through their first extracellular loop
(Cho et al., 2007; Milstein et al., 2007; Tomita et al., 2005a).
Neuronal AMPA receptors have different properties from re-
combinant AMPA receptors. For example, neuronal AMPA
receptors respond to kainate better than glutamate, whereas re-
combinant AMPA receptors respond to glutamate better than
kainate. This discrepancy has been resolved by coexpressing
AMPA receptors with TARPs in recombinant systems, which
results in a robust enhancement of kainate efficacy (Kott et al.,
2007; Tomita et al., 2005a; Turetsky et al., 2005). Furthermore,
glutamate-evoked steady-state current from cells expressing re-
combinant AMPA receptors have typical sigmoid concentration-
response curves (Hollmann and Heinemann, 1994; Robert andNeuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc. 101
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the avian cochlear nucleus and oocytes injected with polyA RNA
from the rat cerebral cortex show a bell-shaped concentration-
response, where the amplitude of the steady-state current
declines at glutamate concentrations above 100 mM (Geoffroy
et al., 1991; Raman and Trussell, 1992; Vlachova et al., 1987).
The mechanisms that give rise to these different concentra-
tion-response relationships remain unclear.
In this study, we have examined the molecular mechanisms
underlying the autoinactivation of neuronal AMPA receptors.
We found that AMPA receptors in mouse cerebellar granule
cells, like the avian cochlear nucleus, also display reduced
steady-state currents at glutamate concentrations above
100 mM, demonstrating that this is also a feature of mammalian
receptors in neurons. Whereas expression of AMPA receptors
alone in Xenopus laevis oocytes did not result in autoinactivated
bell-shaped curves, such curves were obtained upon coexpres-
sion of AMPA receptors with stargazin. Although stargazin
modulates all AMPA receptor subunits, the magnitude of the
stargazin-related reductions in the amplitude of currents evoked
by high concentrations of glutamate depended on subunit
composition and differed for flip and flop splicing isoforms of
AMPA receptors. Our results show that high concentrations of
glutamate promote the dissociation of stargazin from AMPA
receptors, an effect that occurs within a few milliseconds after
receptor desensitization and requires the cytoplasmic domain
of AMPA receptors. Furthermore, we found that this autoinacti-
vation mechanism contributes to short-term modulation of
AMPA receptor activity at synapses. The novel mechanism
described here could tune synaptic transmission upon neuronal
activation or under conditions where ambient levels of glutamate
are elevated.
RESULTS
Stargazin Modulation of AMPA Receptor Function
Depends on Glutamate Concentration
Previous studies have shown that AMPA receptors have a bell-
shaped glutamate concentration-response curve in neurons
from the avian cochlear nucleus, where the amplitude of the
steady-state current declined at glutamate concentrations
above 100 mM, so called ‘‘autoinactivation’’ (Raman and Trussell,
1992; Vlachova et al., 1987). To test whether mammalian AMPA
receptors show similar characteristics, we measured glutamate-
evoked whole-cell currents in mouse cerebellar granule cells.
Glutamate was applied in the continuous presence of cyclothia-
zide (CTZ), which selectively reduces desensitization of AMPA
receptor flip splicing isoforms (and to a lesser extent flop iso-
forms; Partin et al., 1994). Under these conditions, currents
were detected at glutamate concentrations of 3 mM. At concen-
trations of 50 mM and below, the currents did not decline during
5 s applications. At glutamate concentrations of 100 mM and
above, the initial amplitude of the response faded (Figure 1A).
Plots of the mean initial amplitude of the currents against gluta-
mate concentration gave typical sigmoid concentration-
response relationships and EC50 values of approximately
20 mM (data not shown). Whereas the peak amplitudes of
whole-cell currents evoked by 1000 mM glutamate were larger102 Neuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc.than those by 50 mM glutamate (ratio: 1.41 ± 0.07, n = 12),
steady-state currents were consistently and significantly smaller
than the corresponding currents obtained with 50 mM glutamate
(Figures 1A and 1D).
To examine the mechanisms that underlie the reduction in the
amplitude of steady-state AMPA-receptor currents at near-satu-
rating concentrations of glutamate, we used Xenopus laevis
oocytes as a model system (Chen et al., 2003). In oocytes ex-
pressing the flop isoform of the GluR1 AMPA-receptor subunit
(GluR1o) alone, the steady-state currents evoked by 1000 mM
glutamate were larger than the currents evoked by 5 mM gluta-
mate or 10 mM kainate (Figures 1B and 1D). Because native
AMPA receptors in cerebellar granule cells contain the prototyp-
ical TARP stargazin (Chen et al., 2000), we coexpressed starga-
zin and GluR1o in oocytes to better mimic native receptors. In
contrast to GluR1o alone, oocytes coexpressing GluR1o and
stargazin gave larger responses to 5 mM glutamate than to
1000 mM glutamate (Figures 1C and 1D). Similar effects of star-
gazin coexpression were seen for the GluR1 flip isoform (GluR1i;
Figure 1D), and stargazin enhanced kainate-evoked currents
from oocytes expressing both the flip and flop isoforms of
GluR1 (Figures 1C and 1E), as reported previously (Kott et al.,
2007; Tomita et al., 2005a; Turetsky et al., 2005). We also found
that stargazin decreased significantly the steady-state current
ratio for 1000 mM and 5 mM glutamate. This effect of stargazin
was seen without calcium in the extracellular recording solution
(Figure 1F) and was reproduced for other AMPA receptor iso-
forms, although the responses to 1000 mM glutamate were still
larger than those to 5 mM for the GluR2 flip isoform (Figure 1G).
The results suggest that whether neuronal AMPA receptors
show autoinactivated bell-shaped concentration-response
curvesmay depend on the repertoire of AMPA receptor isoforms
expressed. However, for all AMPA receptor subunits examined,
modulation of gating behavior by stargazin depends on gluta-
mate concentration.
Stargazin-Mediated Concentration-Dependent
Modulation of AMPA Receptors Is Not Associated
with a Change in Receptor Number
It is well established that stargazin is involved in AMPA receptor
trafficking (Nicoll et al., 2006; Ziff, 2007). We therefore asked
whether the reduction in current amplitudes at high glutamate
concentrations was due to a reduction in the number of AMPA
receptors at the cell surface. In oocytes coexpressing extracellu-
larly HA-epitope tagged GluR1 and stargazin, we measured the
surface expression of AMPA receptors in the absence or contin-
uous presence of glutamate using chemiluminescence assays
(Tomita et al., 2005a). The surface expression of HA-GluR1i
was not altered by glutamate application (Figure 2A). We then
correlated the glutamate-evoked current at two different gluta-
mate concentrations (10 mMand 500 mM) to the amount of recep-
tors on the cell surface in the presence or absence of stargazin
(Figures 2B and 2C). This allowed us to compare the size of
glutamate-evoked currents with andwithout stargazin in oocytes
with the same number of surface receptors. For both GluR1 flip
and flop receptors, coexpression of stargazin increased the
amplitude of currents evoked by 10 mM glutamate but not
500 mM glutamate (Figures 2B and 2C).
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AMPA Receptors by Stargazin
(A) Glutamate-evoked whole-cell currents were measured in
cultured mouse cerebellar granule cells. The steady-state
current evoked by 50 mM glutamate was larger than that of
1000 mM glutamate in the presence of cyclothiazide (100 mM).
(B and C) Agonist-evoked steady-state currents were re-
corded in oocytes injected with GluR1 flop (GluR1o) alone or
together with stargazin (STG). Steady-state currents evoked
by 1000 mM glutamate were larger than those by 5 mM gluta-
mate or 10 mM kainate (KA) in oocytes expressing GluR1o
alone (20 ng) (B). In contrast, stargazin enhances the response
to kainate relative to glutamate. Furthermore, steady-state
currents evoked by 1000 mM glutamate were smaller than
those by 5 mM glutamate in oocytes expressed GluR1o with
stargazin (0.2 ng each) (C).
(D) Neurons and oocytes coexpressing GluR1 with stargazin
have smaller steady-state currents evoked by 1000 mM gluta-
mate than by 50 mM (n = 12) and 5 mM glutamate (n = 5-7),
respectively.
(E) Stargazin modulates the KA efficacy of GluR1 (n = 6, 7).
(F) Stargazin modulates the ratio of currents evoked by 1000
mM and 5 mM without calcium in the extracellular recording
solution. 1.5 mM calcium chloride are replaced with 0.5 mM
barium chloride/1.0 mM magnesium chloride (n = 5).
(G) Stargazin decreases the steady-state current ratio evoked
by 1000 and 5 mM glutamate in oocytes expressing the AMPA
receptor isoform GluR2 R or Q editing forms, or GluR1/GluR2
heteromers (n = 6, 7). ND indicates that agonist-evoked
currents were undetectable. Data represent the mean ±
SEM from the indicated number of experiments.Concentration-Dependent Modulation of AMPA
Receptors by Stargazin Requires the Cytoplasmic
Domain of AMPA Receptors
To identify the AMPA receptor domains required for the reduced
stargazin-mediated modulation of steady-state currents at high
concentrations of glutamate, we constructed chimeric receptors
in which regions of the AMPA receptor GluR1o and the kainate
receptor GluR6 (which does not interact with stargazin (Chen
et al., 2003; Tomita et al., 2007a)) were exchanged (Figure 3A).
We coexpressed the chimeras with stargazin in oocytes and
measured the ratio of currents evoked by 1000 mM and 5 mM
glutamate. This ratio was less than 1 for each of the chimeras
except for receptors in which the cytoplasmic tail of GluR1
was replaced with the corresponding domain from GluR6
(6Cyto). The 6Cyto chimera gave 1000 mM/5 mM ratios that
were not significantly different from the corresponding ratios ob-
tained for GluR1o receptors without stargazin coexpression
(Figure 3A). Furthermore, replacing the GluR1 ligand-binding
domain with that from GluR6 (6S1S2) resulted in robust reduc-
tion of the ratio of currents evoked by 1000 mM and 5 mM gluta-
mate in the presence of stargazin (Figure 3A), whereas in the
absence of stargazin both 6S1S2 and 6Cyto gave larger
responses to 1000 mM glutamate than to 5 mM glutamate. Star-
gazin increased both the kainate efficacy and the surface
expression of the 6Cyto chimera, demonstrating that the 6Cyto
chimera interacts with stargazin (Figures 3B and 3C). Similar
effects were observed for a chimeric construct in which the flipisoform of GluR1 was used (6Cyto(R1i); Figure 3D). In addition,
deletion of the N-terminal domain of the AMPA receptors
(DNTD) did not alter the effects of stargazin on kainate efficacy
(Tomita et al., 2007b) nor the concentration-dependent modula-
tion of glutamate responses (Figure S1). The results with the
6Cyto chimeras show that the cytoplasmic tail of GluR1 is
required for glutamate concentration dependent modulation of
stargazin-mediated AMPA receptor activity, and the results
with the 6S1S2 chimera suggest that this modulation is influ-
enced by conformational changes that occur at the level of the
ligand-binding domain.
Glutamate Promotes the Dissociation of Stargazin
from AMPA Receptors
Because the effect of stargazin to potentiate AMPA receptor
activity was reduced at high concentrations of glutamate
(Figures 2B and 2C), we hypothesized that stargazin does not
interact with AMPA receptors under these conditions. Indeed,
previous coimmunoprecipitation experiments demonstrated
that prolonged exposure of purified TARP g-3/AMPA receptor
complexes to 100 mM glutamate reduced the association of
the related TARP isoform g-3 with native AMPA receptors (To-
mita et al., 2004).
To test the hypothesis that glutamate promotes the dissocia-
tion of stargazin, stargazin/GluR1 complexes were immunopuri-
fied with anti-stargazin antibody from oocytes coexpressing
GluR1 and stargazin, followed by the addition of glutamate toNeuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc. 103
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dissociation of GluR1 AMPA receptors from stargazin, an effect
that was blocked by the competitive AMPA-receptor antagonist
CNQX (Figure 4A). Similar results were obtained from brain
homogenates (Figure S2A). Importantly, the same glutamate
treatment of immunocomplexes containing stargazin and
6Cyto did not cause dissociation (Figure 4A), supporting the
idea that glutamate-induced dissociation of stargazin is respon-
sible for the reduced steady-state currents seen at high concen-
trations of glutamate. The glutamate-mediated dissociation of
stargazin and GluR1 depended on glutamate concentration,
with a mean effective concentration of 16 mM (Figure 4B). Since
AMPA receptor currents evoked by kainate did not show bell-
Figure 2. Concentration-DependentModulation of AMPAReceptors
by Stargazin Is Not Due to Changes in Surface Expression
(A) Oocytes were injected with extracellular HA epitope-tagged GluR1 flip (HA-
GluR1i) and stargazin transcripts, and the surface expression of HA-GluR1i
was quantified by chemiluminescence (n = 6). The application of 1000 mM
glutamate did not alter the surface expression of HA-GluR1i. Signal from
oocytes injectedwith nontaggedGluR1 and stargazin was accounted as back-
ground.
(B) Surface expression of HA-GluR1i (n = 9) and steady-state currents evoked
by 10 mM and 500 mM glutamate (n = 5) were measured in parallel in oocytes
injected with different amounts of HA-GluR1i cRNA and stargazin (STG). Star-
gazin modulates AMPA receptor function evoked by 10 mM glutamate, but not
by 500 mM glutamate.
(C) The experiments in (B) were repeated in oocytes expressing GluR1o. Data
represent the mean ± SEM from the indicated number of experiments.104 Neuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc.shaped concentration-response curves when AMPA receptors
were coexpressed with stargazin (Tomita et al., 2007b), we
also examined the effect of kainate in coimmunoprecipitation
assays and found that kainate did not result in the dissociation
of GluR1 and stargazin (Figures S2B and S2C).
The dissociation curve in Figure 4B allowed us to calculate the
fraction of stargazin bound to AMPA receptors at different
concentrations of glutamate and to simulate glutamate concen-
tration-response curves for AMPA receptors when they are
coexpressed with stargazin (Figure 4C). Recombinant GluR1o
channels showed a typical sigmoid curve, with an EC50 of about
10 mM and a Hill coefficient close to 1 (Figures 4C and 4D, inset).
Stargazin coexpression decreases the glutamate EC50 value for
steady-state currents about 5-fold (Kott et al., 2007; Priel et al.,
2005; Tomita et al., 2005a; Turetsky et al., 2005; Yamazaki
et al., 2004). After normalization for receptor number, the
currents evoked by 10 mM glutamate were increased by a factor
of about 4 (Figures 2B and 2C). These results can be used to
construct a hypothetical concentration-response curve for
GluR1o channels when coexpressed with stargazin (Figure 4D,
inset). The sum of the two curves in Figure 4D (weighted by the
fraction of channels with and without bound stargazin,
Figure 4B) is similar to the curves obtained experimentally from
oocytes coexpressing GluR1o and stargazin (Figure 4C).
Preventing Stargazin Dissociation Enhances
Steady-State Currents Evoked by High Concentrations
of Glutamate
If stargazin dissociation gives rise to glutamate-dependent
modulation of AMPA receptors, then preventing dissociation of
stargazin and AMPA receptors should eliminate it. To test this
prediction directly, we generated GluR1-stargazin tandem
proteins in which the N terminus of stargazin was directly fused
to the C-terminal end of GluR1 (Figure 5A). Oocytes injected with
the GluR1o-stargazin tandem construct responded to low
concentrations of glutamate similarly to oocytes coinjected
with GluR1o and stargazin (Figure 5B). The efficacy of kainate
was also enhanced to an extent similar to that when GluR1o
and stargazin were coexpressed as separate proteins
(Figure 5C). Coexpression of stargazin with the GluR1o-starga-
zin tandem protein did not further enhance glutamate-evoked
currents or kainate efficacy (Figures 5B and 5C). The GluR1o-
stargazin tandem therefore forms functional channels that
exhibit signature characteristics of stargazin’s effects on AMPA
receptor properties. Importantly, steady-state responses of the
GluR1o-stargazin tandem receptors did not decline at high
glutamate concentrations (Figure 5D), suggesting that the
decline in coexpression experiments is due to the dissociation
of stargazin from AMPA receptors.
To analyze the kinetics of stargazin dissociation from AMPA
receptors, we conducted fast application experiments on
outside-out patches from tsA201 cells transfected with GluR1i,
GluR1i and stargazin, or a GluR1i-stargazin tandem construct.
Typical currents recorded in the three types of patch in response
to 100 ms applications of 10 mM glutamate are shown in
Figure 6A, where the peak amplitudes have been normalized to
allow comparison of the relative steady-state currents. Similar
to our results in oocytes (Figure 5D), steady-state currents
Neuron
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peak, n = 6) than they were for GluR1i with stargazin (4.0% ±
0.7%, n = 5; p < 0.005) (Figures 6A and 6B). In contrast, the effect
of stargazin to slow desensitization was similar in the GluR1i-
stargazin tandem, as can be seen in the inset to Figure 6A where
the decays of the two scaled currents are virtually identical. Biex-
ponential fits to the decays of the two types of responses gave
similar values for both the time constants of the fast and
slow components (tf and ts = 2.5 ± 0.7 ms and 10.2 ± 1.5 ms,
GluR1i + stargazin; 3.0 ± 0.4 ms and 10.7 ± 1.4, GluR1i-starga-
zin), as well as the relative amplitude of the slow component
(As = 37.3% ± 5.7% versus 32.7% ± 3.3%) (Figure 6B).
Comparison of other receptor properties indicated that
steady-state currents were selectively enhanced in the GluR1i-
stargazin tandem protein. The kinetics of deactivation was not
different for GluR1i with stargazin and the GluR1i-stargazin
tandem. Hill-type fits to concentration-response data for peak
currents gave EC50 values for GluR1i + stargazin (570 mM) and
GluR1i-stargazin (607 mM) that were similar to the corresponding
value reported for GluR1i alone (717 mM; Robert and Howe,
2003); and, unlike steady-state currents, peak currents did not
decline at high glutamate concentrations in any of the three
conditions. Measurements of peak current amplitudes with and
without CTZ (an indication of open probability [Popen] at the
Figure 3. The Cytoplasmic Domain of AMPA Recep-
tors Regulates Stargazin-Mediated Modulation of
AMPA Receptors
Oocytes were injectedwith 20 ngGluR1 flop (GluR1o) cRNA or
GluR6 cRNA. Stargazin (STG) (0.1 ng) was injected with
GluR1o and GluR1o chimeric constructs (0.2 ng) as indicated.
Steady-state currents evoked by 5 mM or 1000 mM glutamate
were measured by TEVC recording (n = 9–11). (A) Replacing
the cytoplasmic domain of GluR1o with that of GluR6
(6Cyto) disrupted the concentration-dependent modulation
of AMPA receptor function by stargazin, whereas replacing
the ligand-binding domain (S1S2) of GluR1 with that of
GluR6 (6S1S2) enhanced it. Green and blue asterisks indicate
a significant difference compared with GluR1o with STG and
GluR1 alone, respectively. Stargazin increases kainate effi-
cacy (B) and the surface expression (C) of both GluR1o and
6Cyto as measured by chemiluminescence (n = 9) and TEVC
recording (n = 9–13). (D) Replacing the cytoplasmic domain
of GluR1 flip (GluR1i) with that of GluR6 [6Cyto(R1i)] also dis-
rupted the concentration-dependent modulation of AMPA
receptor function by stargazin (n = 5, 6). Data represent the
mean ± SEM from the indicated number of experiments.
peak response; Cho et al., 2007) gave similar
results for GluR1i with stargazin and the GluR1i-
stargazin tandem. The ratio of the peak currents
with and without CTZ was 1.28 ± 0.04 (n = 5)
for the tandem receptor protein and 1.32 ± 0.05
(n = 5) for GluR1i coexpressed with stargazin.
Both values were significantly smaller than the ratio
obtained for GluR1i alone (1.54 ± 0.02, n = 4; p <
0.05, one-way ANOVA). The 10%–90% rise times
of the currents without CTZ in these experiments
were similar for all three receptor types (GluR1i:
282 ± 44 ms; GluR1i + stargazin, 330 ± 44 ms; GluR1i-stargazin,
250 ± 36 ms).
The results show that the primary difference between GluR1i-
stargazin tandem receptors and the receptors in the GluR1i with
stargazin coexpression experiments is the amplitude of the
steady-state currents during sustained applications of gluta-
mate. The results therefore imply that receptor desensitization
promotes the dissociation of stargazin/AMPA receptor com-
plexes and that the difference between the currents seen for
tandem receptors and the receptors in the GluR1i/stargazin co-
expression experiments (Figure 6A) reflects the rate at which
stargazin dissociates. We therefore averaged the glutamate-
evoked currents for GluR1i with stargazin and subtracted the
mean waveform from the corresponding mean for GluR1i-star-
gazin receptors (after scaling the currents to have the same
peak amplitude). The resultant difference current is shown in
Figure 6C. The difference current develops exponentially with
a time constant of 0.65 ms. Similar results were also obtained
with GluR4i-stargazin tandem receptors (Figure S3).
The effect of stargazin to speed recovery from desensitization
(Priel et al., 2005) contributes to stargazin’s enhancement of
steady-state currents. We therefore compared recovery in two-
pulse experiments for GluR1i with stargazin and the GluR1i-star-
gazin tandem (Figure 6D). At brief intervals the recovery curvesNeuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc. 105
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Receptors from Stargazin in a Concentra-
tion-Dependent Manner
(A and B) Oocytes were injected with cRNA of
GluR1, GluR1 containing the cytoplasmic domain
of GluR6 (6Cyto), and stargazin (STG). Solubilized
membranes from oocytes were immunoprecipi-
tated with anti-stargazin antibody. Beads were
then washed with glutamate at the indicated
concentrations and bound proteins were detected
by western blotting. (A) Glutamate (100 mM) disso-
ciates stargazin from GluR1, but not 6Cyto. CNQX
(100 mM) prevents the dissociation of GluR1 from
stargazin. (B) Glutamate dissociates GluR1 from
stargazin in a concentration-dependent manner
(n = 5). The amount of stargazin was unaltered
by glutamate application.
(C) The steady-state concentration-response
curves of GluR1o with (n = 7) and without stargazin
(n = 5). Current amplitudes were normalized to the
response evoked by 1000 mM glutamate.
(D) Simulated concentration-response curves of
AMPA receptors with and without stargazin. Star-
gazin enhances steady-state AMPA-receptor
currents [f(x)] 4-fold and decreases the EC50 value
by a factor of 5 [4f0 (x), small inset]. Total simulated evoked currents were calculated as the sum of the percentage of stargazin-bound AMPA receptors and star-
gazin-dissociated AMPA receptors. For comparison between GluR1 with and without stargazin, currents were normalized to the response evoked by 1000 mM
glutamate. Simulated concentration-response curves (D) resembled concentration-response curves obtained experimentally (C).
Data in (B) and (C) represent the mean ± SEM from the indicated number of experiments.were similar. At intervals longer than 40 ms (where recovery was
about one-third complete), recovery was slower in the coexpres-
sion experiments, suggesting that at these longer intervals some
of the receptors that recover from desensitization no longer have
stargazin associated with them. Comparison of recovery from
desensitization for GluR4i with stargazin and the GluR4i-starga-
zin tandem supported a similar conclusion.
If it is desensitization that promotes the dissociation of starga-
zin, then the concentration dependence of stargazin dissociation
and desensitization should be similar. One consistent effect of
stargazin and other TARPs is to markedly enhance the slow106 Neuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc.component evident in deactivation decays (Cho et al., 2007; Mil-
stein et al., 2007; Zhang et al., 2006). Therefore if steady-state
desensitization promotes the dissociation of stargazin, it should
reduce stargazin enhancement of the amplitude of the slow
component of deactivation. We therefore measured receptor
deactivation in the continuous presence of 8 mM glutamate for
GluR4i alone, GluR4i coexpressed with stargazin, and GluR4i-
stargazin tandem receptors. As expected, the presence of
8 mM glutamate reduced the size of the peak currents evoked
by 2 ms applications of 10 mM glutamate by approximately
50% (Robert and Howe, 2003). Both coexpression of stargazinFigure 5. Blocking the Dissociation of Stargazin from
AMPA Receptors Prevents Concentration-Dependent
Modulation of AMPA Receptors
(A) The topology of GluR1, stargazin, and the tandem proteins
of GluR1 and stargazin, in which the C terminus of GluR1 is
fused to the N terminus of stargazin.
(B) Stargazin enhanced currents evoked by 5 mM glutamate
through GluR1o channels. Oocytes injected with 0.05 ng of
the cRNA encoding the GluR1o-stargazin tandem construct
responded better than those with GluR1o cRNA (20 ng) alone.
Coexpression of stargazin failed to cause a further enhance-
ment of current amplitude.
(C) The GluR1o-stargazin tandem protein modulates kainate
efficacy to a similar extent as GluR1o and stargazin. The coex-
pression of STGwith the GluR1o-stargazin tandem protein did
not produce any additional enhancement of the response.
(D) In contrast to receptors expressed in response to the coex-
pression of GluR1o and stargazin, the GluR1o-stargazin
tandem protein did not show a reduction in current amplitudes
at high glutamate concentrations. Coexpression of stargazin
had no effect on the concentration-response behavior of
GluR1o-stargazin receptors. Data represent the mean ±
SEM (n = 5, 6).
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Autoinactivation of Neuronal AMPA ReceptorsFigure 6. Stargazin Dissociates from AMPA
Receptors within a Few Milliseconds after
Receptor Desensitization
(A and B) Responses to 200 ms applications of
10 mM glutamate in outside-out patches from
tsA201 cells transfected with GluR1i alone, GluR1i
with stargazin, or the GluR1i-stargazin tandem.
Each trace is the mean of 10 to 20 trials from indi-
vidual patches. The currents were scaled so the
peak amplitudes were the same (individual peak
currents were 1.04–1.71 nA). The inset shows the
decays of the currents scaled to the same ampli-
tude after subtracting the respective steady-state
currents to compare better the respective rates of
desensitization. Note that in the inset the record
for GluR1i + stargazin (green) and the record for
the GluR1i-stargazin tandem (black) are virtually
identical. (B) Weighted time constants (left) and
steady-state currents (right) obtained from biex-
ponential fits to the decays of currents (n = 5–6).
(C) Current obtained by subtracting the mean
response for GluR1i and stargazin from the mean
response for the GluR1i-stargazin tandem (data
from all patches were averaged and the peak
amplitudes were scaled as in panel [A]). The inset
shows the first 10 ms of the difference current,
which decayedmonoexponentially (tau = 0.65ms).
(D) Data for recovery from desensitization ob-
tained from two-pulse protocols (n = 5–6). Smooth
curves are double Hodgkin-Huxley fits (Zhang
et al., 2006). Stargazin speeds recovery (relative
to GluR1i alone) and the rates of recovery for
GluR1i with stargazin and the GluR1i-stargazin
tandem are similar for interpulse intervals less
than 40 ms.
(E and F) Deactivation protocols (10 mM gluta-
mate for 2 ms) in the absence (black) and contin-
uous presence of 8 mM glutamate (red). The pres-
ence of 8 mM glutamate reduced the peak current
by about 50% and the pairs of records in each
patch have been scaled so that the deactivation
decays have the same amplitude. The decays
were fitted with biexponential functions and the
slow component of decay from these fits is shown
for each record (dotted curves). (F) The relative
amplitude of the slow component of deactivation
in the absence (open bars) and presence (filled
bars) of 8 mM glutamate. Exposure of the receptors to 8 mM glutamate significantly reduced the amplitude of the slow component for GluR4i with stargazin
(p < 0.05), but not for GluR4i alone or GluR4i-stargazin tandem receptors (n = 4–6).
Data in (B), (D), and (F) represent the mean ± SEM from the indicated number of experiments.and the GluR4i-stargazin tandem increased the amplitude of the
slow component of deactivation under control conditions, and
pre-exposure of the receptors to 8 mM glutamate reduced the
relative amplitude of this component in the coexpression exper-
iments but not for GluR4i-stargazin tandem receptors (Figures
6E and 6F). The results are consistent with the conclusion that
desensitization promotes the dissociation of stargazin from
AMPA receptors.
Preventing Stargazin Dissociation Alters Short-Term
Modulation of Synaptic Transmission
Our fast application results indicate that glutamate-mediated
dissociation of stargazin and AMPA receptors occurs withina few milliseconds, suggesting that this mechanism might
contribute to basal synaptic transmission and short-term modu-
lation of synaptic transmission. To examine possible roles of
stargazin dissociation in synaptic transmission under basal
conditions, we examined the effects of stargazin dissociation
on basal synaptic transmission using cerebellar granule cell
cultures from stargazermice, which lack functional AMPA recep-
tors (Chen et al., 2000; Cho et al., 2007; Milstein et al., 2007). We
overexpressed GFP alone, stargazin/GluR4i/GFP, or GluR4i-
stargazin tandem/GFP in stargazer cerebellar granule cells and
measured the amplitude and kinetics of spontaneous EPSCs
from GFP positive neurons. As previously shown, we did not
observe EPSCs in neurons transfected with GFP alone (n = 4).Neuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc. 107
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AMPA Receptors Modulates Short-Term
Modulation of Synaptic Transmission
(A–C) Whole-cell data from cerebellar granule
cells. AMPA receptor-mediated spontaneous
EPSCs were not observed in cerebellar granule
cells from stargazer mice and in stargazer cere-
bellar granule cells transfected with GFP alone
(MOCK) (n = 4) (N.D. not detectable). The expres-
sion of GluR4i with stargazin (STG) (black) or
GluR4i-STG tandem (red) rescued synaptic trans-
mission in neurons from stargazermice. The ampli-
tude (A andB) and decay (B andC) of spontaneous
EPSCs in stargazer granule cells transfected with
GluR4i with stargazin or GluR4i-stargazin tandem
were not significantly different (n = 6).
(D and E) Whole-cell paired recordings from
primary cultured hippocampal neurons. Neurons
were transfected with cDNAs encoding GFP
alone, GFP with GluR4i and stargazin, GFP with
GluR4i-stargazin tandem. Transfected neurons
were identified by GFP expression. Putative pairs
of morphologically connected neurons were iden-
tified visually and both neurons were patched
simultaneously. Once synaptic connectivity was confirmed, pairs of 1 ms jumps 70 mV to + 20 mV were applied to the presynaptic neuron at an interval of
20 ms. Neurons expressing GFP alone (MOCK) and with GluR4i and stargazin showed paired-pulse depression, whereas paired-pulse facilitation was observed
in neurons expressing GFP and the GluR4i-stargazin tandem (n = 4–6). (**p < 0.01, one-way ANOVA). The evoked EPSCs were blocked by the addition of the
AMPA receptor antagonist CNQX (100mM, red traces in [D]). All data represent the mean ± SEM.On the other hand, we observed frequent EPSCs in neurons ex-
pressing stargazin/GluR4i/GFP or GluR4i-stargazin tandem/
GFP (n = 6), suggesting that both receptors are incorporated
into synapses. The decays and amplitude of the EPSCs were
similar for stargazin/GluR4i and GluR4i-stargazin tandem-trans-
fected cells, suggesting that all AMPA receptors interact with
stargazin under basal conditions in cerebellar granule cells
(Figures 7A and 7B).
Next we examined whether stargazin dissociation plays a role
in short-term modulation of synaptic transmission. We first at-
tempted to find paired neurons with GFP transfected cerebellar
granule cells. However, the high density of the cultured neurons
and the low number of synapses prevented us from finding
synaptically connected neurons. We therefore turned to hippo-
campal cultures, which have been used successfully for paired
recordings. We overexpressed GFP with stargazin/GluR4i or the
GluR4i-stargazin tandem in hippocampal cultured neurons.
Simultaneouswhole-cell recordingsweremade from aGFP-posi-
tive and neighboring neurons. In nontransfected neurons and
neurons expressing stargazin and GluR4i, we observed paired
pulse depression when EPSCs were evoked at an interval of 20
ms (Figure 7D). The ratio of the peak amplitudes of the second
and first EPSC in neurons expressing stargazin and GluR4i was
0.78 ± 0.05 (Figure 7E). In contrast, we observed paired pulse
facilitation in neurons expressing the GluR4i-stargazin tandem
receptor (Figures 7D and 7E), with a paired pulse ratio of 1.41 ±
0.19. The results suggest that stargazin dissociation contributes
to short-term modulation of synaptic transmission.
DISCUSSION
This study demonstrates that stargazin modulation of AMPA
receptor activity varies with glutamate concentration. The108 Neuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc.reduced stargazin modulation at high concentrations of gluta-
mate persisted when current amplitudes were normalized for
potential differences in receptor number, demonstrating that
it does not result from glutamate-induced receptor internaliza-
tion or modulation of stargazin’s known effects on AMPA
receptor trafficking. The glutamate-dependent modulation of
current amplitude requires the cytoplasmic domain of AMPA
receptors and appears to result from the rapid dissociation of
stargazin after receptor desensitization. The dynamic nature of
stargazin regulation of AMPA receptor function allows stargazin
to play a central role in short-term modulation of synaptic trans-
mission.
Glutamate Concentration-Dependent Responses
of AMPA Receptors in Different Types of Neurons
We show here that AMPA receptors in mouse cerebellar granule
cells and recombinant AMPA receptors coexpressed with star-
gazin show autoinactivated concentration-response behavior
similar to that described previously for AMPA receptors in avian
neurons (Raman and Trussell, 1992; Vlachova et al., 1987).
However, it has been reported that AMPA receptors in rat hippo-
campal pyramidal cells have a sigmoid concentration curve
response to glutamate (Patneau andMayer, 1991). One explana-
tion for these different results is that AMPA receptors in the
hippocampus lack TARPs (TARPless AMPA receptors).
However, TARP g-8 knockout mice show a loss of surface
AMPA receptor activity in the hippocampus (Rouach et al.,
2005), indicating that most surface AMPA receptors in the hippo-
campus interact with TARPs (TARPin AMPA receptors).
Another possible explanation for the different concentration-
response relationships is that AMPA receptors in the hippo-
campus are composed of different subunits than receptors
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dependent response of all AMPA receptors (Figure 1G), but the
modulation was less robust for the GluR2 flip isoform and the
currents evoked by 1000 mM glutamate were still larger than
those evoked by 5 mM glutamate (Figure 1G). Interestingly, the
size of the reduction in current amplitudes at high glutamate
concentrations was larger for flop splice isoforms than for the
corresponding flip isoforms for both GluR1 and GluR2 receptors
(Figures 1D, 1G, 2B, and 2C). In cerebellar granule cell neurons,
where the expression of flip and flop isoforms varies during early
postnatal development (Mosbacher et al., 1994), the ratio of
steady-state currents evoked by 1000 mM and 50 mM glutamate
were smallest in cells in which PEPA (a drug that selectively
potentiates glutamate-evoked currents for flop GluR isoforms)
resulted in the largest enhancement of glutamate-evoked
responses. Importantly, all AMPA receptor subunits and hetero-
mers are modulated by stargazin in a glutamate-dependent and
calcium independent manner, albeit to different extents.
The Mechanism Underlying the Bell-Shaped
Concentration-Response Curves
Bell-shaped concentration-response curves have also been re-
ported for acetylcholine receptors (Colquhoun and Ogden,
1988; Giniatullin et al., 2005). Both the peak amplitude and the
steady state current of acetylcholine receptors decline at milli-
molar concentrations of acetylcholine, and this ‘‘fall-off’’ has
been explained as an effect of acetylcholine as an open channel
blocker at high concentrations or by preferential occupancy of
different desensitization states of the receptor at low and high
agonist concentrations (Colquhoun and Ogden, 1988; Giniatullin
et al., 2005).
It was suggested that similar reductions in AMPA-receptor
peak currents at near-saturating glutamate concentrationsmight
reflect glutamate binding to divalent cations and subsequent
open channel block by the chaotropic species (Raman and Trus-
sell, 1992). However, the steady-state current of AMPA recep-
tors declines in the micromolar range (Figure 4C) (Raman and
Trussell, 1992; Vlachova et al., 1987), making it unlikely that
the reductions result from open channel block. Bell-shaped
concentration-response curves were also observed for steady-
state currents of native kainate receptors and were explained
by the different concentration dependence of activation and
desensitization (Paternain et al., 1998).
Our results suggest that stargazin dissociates from AMPA
receptors within milliseconds after receptor desensitization.
With the exception of the size of steady-state currents, the
GluR1-stargazin tandemprotein andGluR1/stargazin complexes
showed no difference in receptor properties, including rise time
and peak open probability, or deactivation and desensitization
kinetics. Because the effect of stargazin to slow the rate at which
AMPA receptors desensitize (Chen et al., 2000; Kott et al., 2007;
Priel et al., 2005; Tomita et al., 2004, 2005a; Turetsky et al., 2005;
Yamazaki et al., 2004) was unaltered in the tandem receptors, we
conclude that dissociation of stargazin from AMPA receptors
occurs after desensitization. Further support for this conclusion
is provided by our results at low glutamate concentrations for
GluR4i (Figures 6E and 6F) and from comparisons of the relative
amplitudes of the currents evoked by 1000 mM and 5 mM gluta-mate with and without stargazin for GluR flip and flop isoforms
in the absence and presence of cyclothiazide. Cyclothiazide
reduced stargazin mediated concentration-dependent modula-
tion of the GluR1 flip isoform, but not the GluR1i flop isoform
(Figure S4).
We suggest that in resting and open channel states, the
majority of receptors have stargazin associated with them, but
the equilibrium between stargazin-coupled and stargazin-
uncoupled forms of the receptor shifts toward the stargazin-
uncoupled form once the receptors desensitize (Figure S5). An
estimate of the fraction of desensitized receptors still functionally
coupled with stargazin can be made from the amplitudes (rela-
tive to the peak currents) of the steady-state responses at
10 mM glutamate for GluR1i alone, GluR1i with stargazin, and
the GluR1i-stargazin tandem receptor, which were about
0.3%, 4%, and 8%, respectively. These relative amplitudes indi-
cate that roughly half of the receptors contributing to the steady-
state currents at near-saturating glutamate have stargazin asso-
ciated with them. Since stargazin increases the rate of recovery
from desensitization, stargazin-coupled receptors will recover
more often and contribute more to the steady-state current.
Assuming that re-association of stargazin with the receptors is
minimal before the receptors once again desensitize, simulations
using the simple kinetic mechanism in Figure S5 suggest that
about two-thirds of desensitized receptors are no longer effec-
tively coupled to stargazin. What fraction of the total receptor
population have stargazin associated with them will depend on
the fraction of the receptors desensitized at steady-state, which
will increase with glutamate concentration. As a larger fraction of
receptors occupy desensitized states as the concentration of
glutamate is increased, a larger fraction of the receptors contrib-
uting to the steady-state responses will no longer be effectively
coupled with stargazin and stargazin enhancement of receptor
gating will be increasingly reduced.
The Kinetics of Stargazin Dissociation from AMPA
Receptors
Previous studies have demonstrated that the first extracellular
loop of stargazin slows desensitization and deactivation of
AMPA receptors and controls EPSC decay in neurons (Cho
et al., 2007; Milstein et al., 2007; Tomita et al., 2005a). Our results
indicate that concentration-dependent modulation of AMPA
receptors occurs just after they desensitize. The kinetics of the
difference current obtained from the GluR1-stargazin tandem
protein and theGluR1/stargazin complex (Figure 6C), and the cor-
responding results for the GluR4-stargazin tandem (Figure S3C),
suggest that stargazin-receptor interactions disengage within
milliseconds. Our oocyte studies indicate that stargazin modula-
tion is re-acquired within 1 s (Figure 1C). It seems unlikely that
two large multidomain membrane proteins would completely
dissociate from each other on this time scale. It is possible,
however, that a small number of key functional interactions
responsible for stargazin modulation of gating are lost initially
as a result of conformational changes associated with desensiti-
zation. Our biochemical data in oocytes (Figure 4B) show that
prolonged exposure to high concentrations of glutamate
completely dissociates stargazin. It is possible that brief applica-
tions of glutamate induce rapid and reversible uncoupling ofNeuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc. 109
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mate may result in the complete dissociation and re-distribution
of receptors. Indeed, we have previously reported that application
of AMPA to neurons for 1 min induces the internalization of AMPA
receptors, but not stargazin (Tomita et al., 2004). Recently,
a contribution of AMPA receptor desensitization to distribution
of in moving AMPA receptors at synapses was reported (Heine
et al., 2008) and our study indicates that AMPA receptor-desen-
sitization dependent trafficking may be influenced by dynamic
regulation of TARP/AMPA receptor interactions.
We identified the cytoplasmic domain of the AMPA receptor as
a critical region for the dissociation of AMPA receptors from star-
gazin. It remains unclear, however, how glutamate binding to the
extracellular domain of AMPA receptors results in the dissocia-
tion of stargazin and AMPA receptors through the cytoplasmic
domains of AMPA receptors. Agonist binding to extracellular
domains of other receptors, for example receptor tyrosine
kinases or G protein coupled receptors, can result in phosphor-
ylation of intracellular residues or the activation of cytoplasmic
factors. Whether similar cytoplasmic signaling events contribute
to glutamate-induced dissociation of stargazin requires further
investigation.
AMPA Receptor Structure and Stargazin Dissociation
The structure of the ligand-binding domain (S1-S2) of AMPA
receptors in complex with various agonists and drugs has
been resolved at the atomic level, and it has been shown that
closure of the S1-S2 binding cleft results in the opening of the
receptor channels and that desensitization is associated with re-
arrangements at the dimer interface (Armstrong et al., 2006;
Gouaux, 2004; Mayer and Armstrong, 2004). Previous studies
from our laboratory showed that stargazin interacts with the
extracellular glutamate-binding domain of AMPA receptors (To-
mita et al., 2007b). Interestingly, chimeras in which the ligand-
binding domain (S1-S2) of the GluR1 flop AMPA receptor were
replaced with the GluR6 kainate receptor showed even greater
loss of stargazin modulation of steady-state currents at high
glutamate concentrations (Figure 3A), underscoring the impor-
tance of the ligand binding domain for the effects reported
here and supporting the idea that structural changes in the
ligand-binding domain contribute to stargazin dissociation
from AMPA receptors.
The number of stargazin molecules that bind to each receptor,
and the number that must dissociate to lose effects on gating,
are unknown. The GluR1-stargazin tandem protein forms func-
tional AMPA receptors, suggesting that the stoichiometry is
1:1. However, some stargazin molecules in GluR1-stargazin
tandem proteins may not be functionally incorporated into active
receptors. Regardless, this GluR1-stargazin tandem protein
might be useful for studying the structure of AMPA receptor/star-
gazin complexes.
Functional Implications of Receptor Autoinactivation
The dynamic nature of stargazin regulation of AMPA receptor
function may allow stargazin to play a central role in short-term
modulation of neuronal function. Our results in hippocampal
neurons demonstrate that the dissociation of stargazin can
contribute to paired pulse depression. The size of this effect110 Neuron 61, 101–112, January 15, 2009 ª2009 Elsevier Inc.would be expected to depend on presynaptic firing frequencies
and the kinetics of stargazin dissociation and reassociation in
neurons. Although steady-state currents do not contribute to
synaptic transmission, they are responsible for the excitotoxicity
that occurs when ambient levels of glutamate are elevated. The
dissociation of stargazin that accompanies desensitization of the
receptors at glutamate concentrations in the low micromolar
range may be a mechanism to protect neurons from excitotoxic
damage.
EXPERIMENTAL PROCEDURES
Antibodies
The following antibodies were used: rabbit polyclonal antibodies to stargazin
and pan-TARP (Tomita et al., 2003), GluR1, GluR2/3, GluR4, and GluR6/7
(Millipore), rat monoclonal antibody to HA epitope (Roche).
Plasmid Construction
Using the chimeric primers for GluR1 and GluR6, mutated PCR fragments
were subcloned using appropriate restriction enzymes or standard overlap
PCR methods (Tomita et al., 2005a). All DNA constructs were verified by
sequencing.
Electrophysiology Using Xenopus laevis Oocytes
Two electrode voltage clamp recordings were performed as described (Tomita
et al., 2004). Briefly, cRNAs were transcribed in vitro using the T7 mMessage
mMachine kit (Ambion) and injected at the indicated amounts into defollicu-
lated Xenopus laevis oocytes. Two-electrode voltage-clamp analysis (Eh =
70 mV) was carried out 2–3 days postinjection at room temperature. Each
agonist was bath applied in recording solution (90 mM NaCl, 1.0 mM KCl,
1.5 mM CaCl2, and 10 mM HEPES [pH = 7.4]).
Surface Labeling of Oocytes
Surface labeling was performed as described (Tomita et al., 2005a). Briefly,
3 days after injection, oocytes were incubated for 1 hr with 0.25 mg/ml rat
anti-HA antibody (3F10, Roche) followed by a 30 min incubation with HRP
conjugated anti-rat Ig. Individual oocytes were then placed into 100 ml Super-
Signal ELISA Femto Maximum Sensitivity Substrate (Pierce) and chemilumi-
nescence was quantified using a Veritas Microplate Luminometer (Turner
Biosystems). Oocytes were treated with glutamate (1 mM) for 10 min. Gluta-
mate was present in all experimental procedures except for the chemilumines-
cence reaction.
Immunoprecipitation
For coimmunoprecipitations (Tomita et al., 2003), oocyte membranes were
suspended in lysis buffer containing TEEN (25 mM Tris-Cl [pH 7.4], 1 mM
EDTA, 1 mM EGTA, 150 mM NaCl), 1% Triton X-100, protease inhibitors
(1 mM PMSF, 10 mg/ml leupeptin) and centrifuged at 37,000 3 g for 40 min.
The supernatants were then incubated with 3 mg of affinity-purified antibodies
and 20 ml of protein A sepharose beads. The beads were then washed three
times with 1% Triton in TEEN. For some experiments, glutamate or CNQX
were added for 20 min at 4C and washed once with 1% Triton X-100 in
TEEN. Bound proteins were eluted by heating the resin in 20 ml of 1X SDS-
PAGE sample buffer and analyzed by SDS-PAGE.
Patch-Clamp Recording
Whole-cell recordings from cerebellar granule cells and recordings from
outside-out patches from transfected tsA201 cells were performed as previ-
ously described (Cho et al., 2007; Robert and Howe, 2003). Low-density
hippocampal neuron cultures (63 104/cm2) weremaintained as described (To-
mita et al., 2005b) and transfected with cDNA encoding eGFP (0.2 mg), GluR4 +
stargazin (1 mg), or GluR4-stargazin tandem (1 mg) at DIV 8 with calcium phos-
phate. Paired-recording was performed at 10–12 DIV with two EPC 9 ampli-
fiers (HEKA) in external solution containing (in mM): 10 HEPES, 140 NaCl,
2.5 KCl, 2.5 CaCl2, 1.3 MgSO4, 2.7 MgCl2, and 10 glucose. Patch pipettes
Neuron
Autoinactivation of Neuronal AMPA Receptors(tip resistance 6–8 MU) were filled with recording solution that contained (in
mM): 130 cesium methanesulfonate, 5 HEPES, 5 Mg-ATP, 0.2 Na-GTP, 20
TEA and 5 EGTA, and all recordings were performed at room temperature.
To isolate AMPA receptor-mediated EPSCs, AP-5 (50 mM) and picrotoxin
(100 mM) were added to the external solution. To confirm the EPSCs were
AMPA-receptor mediated, 100mMCNQXwas applied to the bath solution after
each recording. To record evoked EPSCs, isolated cell pairs were selected
and patched simultaneously in the whole-cell mode. Both cells were voltage
clamped at 70 mV. Two voltage jumps (to +20 mV for 1ms) were applied at
a 20 ms interval to a neuron (presynaptic cell), and the EPSC in the other
neuron (postsynaptic cell) was recorded. Currents were analog low-pass
filtered at 3 kHz and digitally sampled at 40 kHz. For each cell pair, 25 events
at 0.2 Hz were recorded and averaged for analysis. Mice were obtained from
Jackson Laboratory andmaintained at the Yale animal facility under the guide-
lines of the Institutional Animal Care and Use Committee.
Fitting and Calculation of Concentration-Response Curves
For the results presented in Figure 5, concentration-response curves of AMPA
receptors alone was fitted to
fðxÞ= 1 1=1+ 10^log10½mM  log10½EC50

:
The fits to the results gave an EC50 of 10 mM and a Hill coefficient of 1.
Because stargazin enhanced AMPA receptor function roughly 4-fold (Tomita
et al., 2005a) and decreases the EC50 to 2 mM (Kott et al., 2007; Priel et al.,
2005; Tomita et al., 2005a; Turetsky et al., 2005; Yamazaki et al., 2004), the
concentration-response curve of AMPA receptors with stargazin was fitted to:
4f0ðxÞ= 43 1 1=1+ 10^log10½mM  log10½EC50

:
The dissociation curve of AMPA receptors from stargazin was fitted to:
FðxÞ= 1=1+ 10^log10½mM  log10½IC50

:
The fits to the results gave an IC50 was 16 mM.
The total evoked current from cells expressing AMPA receptors with starga-
zin was calculated as the sum of curves for AMPA receptors with and without
stargazin, where each curve was weighted by the proportion of each channel
type estimated from the fit to the dissociation curve:
Total=FðxÞ34f0ðxÞ+ ð1 FðxÞÞ3 fðxÞ
All concentration-response curves were normalized to the size of the
response at 1000 mM glutamate.
SUPPLEMENTAL DATA
The Supplemental Data include five supplemental figures and can be found
with this article online at http://www.neuron.org/supplemental/S0896-
6273(08)00962-8.
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